Abstract:first_page Download PDF settings Order Article Reprints Font Type: Arial Georgia Verdana Font Size: Aa Aa Aa Line Spacing:    Column Width:    Background: Open Access Editorial What SARS-CoV-2 Variants Have Taught Us: Evolutionary Challenges of RNA Viruses by Shymaa E. Bilasy Shymaa E. Bilasy Scilit Preprints.org Google Scholar View Publications 1 , Tutik Sri Wahyuni Tutik Sri Wahyuni Scilit Preprints.org Google Scholar View Publications 2 , Mohamed Ibrahim Mohamed Ibrahim Scilit Preprints.org Google Scholar View Publications 3 and Ahmed El-Shamy Ahmed El-Shamy Scilit Preprints.org Google Scholar View Publications 4,* 1 College of Dental Medicine, California Northstate University, Elk Grove, CA 95757, USA 2 Department of Pharmaceutical Science, Faculty of Pharmacy, Natural Product Medicine Research and Development, Institute Tropical Disease, Airlangga University, Surabaya 60286, Indonesia 3 College of Biotechnology, Misr University for Science and Technology, Giza, Egypt 4 Master of Pharmaceutical Sciences Program, College of Graduate Studies, California Northstate University, Elk Grove, CA 95757, USA * Author to whom correspondence should be addressed. Viruses 2024 , 16 (1), 139; https://doi.org/10.3390/v16010139 (registering DOI) Submission received: 4 December 2023 / Accepted: 12 January 2024 / Published: 18 January 2024 (This article belongs to the Special Issue What SARS-CoV-2 Variants Have Taught Us: Evolutionary Challenges of RNA Viruses) Download keyboard_arrow_down Download PDF Download XML Versions Notes Since its discovery in 2019, SARS-CoV-2 still makes the headline news. SAR-CoV-2 is an emerging RNA virus that spread from a seafood market in Wuhan, China, and caused the COVID-19 pandemic. SARS-CoV-2 is a positive sense single-stranded RNA virus of about 30 kb in length that is derived from the Coronaviridae . Up to September 2023, more than 770 million COVID-19 cases and 6.9 million deaths were reported to the World Health Organization (WHO). Around 37 variants of SARS-CoV-2 were reported and they were categorized as variants of concern (VOC) or variants of interest (VOI) or variants being monitored (VBM) [1]. The WHO labeled SARS-CoV-2 Omicron (B.1.1.529) as a variant of concern in November 2021 [2]. This variant was first reported in South Africa, but it quickly became the dominant circulating SARS-CoV-2 worldwide [3,4]. The Omicron viruses continued to genetically evolve with more sub-lineages added to its phylogenetic tree. The genetic divergence of Omicron has been associated with changes in the viral transmissibility, virulence, and ability to evade protective immune response conferred by natural infection or vaccination [5].To shed light on the evolutionary behavior of RNA viruses and how it shapes their epidemiolocal fitness and pathological features, Viruses developed a Special Issue entitled "What SARS-CoV-2 Variants Have Taught Us: Evolutionary Challenges of RNA Viruses". This issue included twenty-four research topics comprising different aspects of SARS-CoV-2 infection. Viral lineages in different geographical locations were discussed by several authors. Omicron and its sub-variants were responsible for COVID-19 -Abstract Truncated-

COVID-19 evolution during the pandemic – Implications of new SARS-CoV-2 variants on disease control and public health policies

COVID-19: Understanding the New Variants of Concern

Evolution and Implications of SARS-CoV-2 Variants in the Post-Pandemic Era

COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective

The Challenge of Emerging SARS-CoV-2 Mutants to Vaccine Development

Digest: Individual- and population-level effects of SARS-CoV-2 evolution and changing preventative measures

Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape

What SARS-CoV-2 Variants Have Taught Us: Evolutionary Challenges of RNA Viruses

COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development

An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution

The biological and clinical significance of emerging SARS-CoV-2 variants

Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants

Emergence of more contagious COVID-19 variants from the coevolution of viruses and policy interventions

Evolving Immune Evasion and Transmissibility of SARS-CoV-2: the Emergence of JN.1 Variant and Its Global Impact.

The potential impact of the spreading of highly transmissible Omicron variant XBB.1.5 and JN.1 on the evolution of SARS-CoV-2

SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants

Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants

The evolution of SARS-CoV-2 and the COVID-19 pandemic

Lessons from SARS‐CoV‐2 and its variants (Review)